Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
ST. LOUIS, April 06, 2016 -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its first quarter earnings on Monday, April 25, 2016 after the market closes and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
This call is being webcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.
A slide presentation will also be posted on Express Scripts’ website. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts’ website for 14 days.
About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected]
